SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-16-001737
Filing Date
2016-12-01
Accepted
2016-12-01 16:55:34
Documents
2
Group Members
ORBIMED ADVISORS LTDORBIMED ASIA GP, L.P.ORBIMED CAPITAL GP III LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 9 ss21780_sc13da.htm SC 13D/A 161215
2 JOINT FILING AGREEMENT ss21780_ex99n.htm EX-99.N 22642
  Complete submission text file 0000947871-16-001737.txt   185468
Mailing Address 1781 - 75TH AVENUE W. VANCOUVER A1 V6P6P2
Business Address 1781 - 75TH AVENUE W. VANCOUVER A1 V6P6P2 604-456-6010
RESPONSE BIOMEDICAL CORP (Subject) CIK: 0000806888 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81850 | Film No.: 162028931
SIC: 8734 Services-Testing Laboratories

Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A